Anika Therapeutics, Inc. — Director's Dealing 2012

Dec 10, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANIKA THERAPEUTICS INC (ANIK)
CIK: 0000898437
Period of Report: 2012-12-07

Reporting Person: SHERWOOD CHARLES H (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-07	Common Stock	M	17127	$1.05	Acquired	335907	Direct
2012-12-07	Common Stock	M	22873	$1.05	Acquired	358780	Direct

Footnotes

F1: Exercise of stock options granted on January 13, 2003 and that vested in four equal installments annually beginning January 13, 2004.